The Oncology InstituteTOI
About: The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
Employees: 825
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
7.8% less ownership
Funds ownership: 27.27% [Q3] → 19.47% (-7.8%) [Q4]
9% less funds holding
Funds holding: 34 [Q3] → 31 (-3) [Q4]
34% less capital invested
Capital invested by funds: $6.98M [Q3] → $4.61M (-$2.37M) [Q4]
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Research analyst outlook
We haven’t received any recent analyst ratings for TOI.
Financial journalist opinion









